Biotech

All Articles

Daiichi pays out Merck $170M to develop lung cancer T-cell engager deal

.Merck &amp Co. has rapidly made back a few of the prices of its Weapon Therapies acquistion, pullin...

BioMarin standstills preclinical gene treatment for heart condition

.After BioMarin performed a springtime well-maintained of its own pipe in April, the provider has ac...

Eisai plants molecular glue SEED along with $1.5 B biobucks deal

.Significant Pharmas remain stuck to the concept of molecular adhesive degraders. The most up to dat...

Life science credit score company unveils along with $600M

.A brand new international life science credit scores company, dubbed Symbiotic Funds, has actually ...

BMS ditches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing yet another major wager from the Caforio period, terminating...

Nuvation stops BET inhibitor after considering stage 1 record

.After looking at stage 1 information, Nuvation Bio has actually made a decision to halt work on its...

' Medical intuition' led FDA advisors to back Zevra's uncommon condition med

.Zevra Rehabs' rare condition drug appears to become on the course to permission this autumn after a...

Pfizer takes $230M struck after axing neglected DMD gene therapy

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics therapy breakdown has blown a $230 mill...

AC Immune observes 'site' potential in Alzheimer's medication records

.After more than 20 years of focus on neurodegenerative ailments, Swiss biotech hvac Immune system c...

GSK goes down ph. 2 HPV vaccine over lack of best-in-class possible

.GSK has ditched a phase 2 human papillomavirus (HPV) vaccination coming from its pipe after making ...